Healthy Returns: Medicaid cuts in Trump's megabill may affect some drugmakers more than othersCNBC • 07/08/25
Novo Nordisk submits higher Wegovy dose to the European Medicines Agency for approvalReuters • 07/08/25
Novo Nordisk: Obesity war heating up, but Danish giant can still be a winnerProactive Investors • 07/08/25
2 S&P 500 Dividend Stocks That Could Climb 17% or More, According to Wall StreetThe Motley Fool • 07/08/25
Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safetyPRNewsWire • 06/26/25
Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law FirmBusiness Wire • 06/25/25
Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. CruzBusiness Wire • 06/24/25